Advisory Committee on Immunization Practices (ACIP), 25567 [E9-12334]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 101 / Thursday, May 28, 2009 / Notices
25567
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Capacity
Building Assistance (CBA) To Improve
the Delivery and Effectiveness of
Human Immunodeficiency Virus (HIV)
Prevention Services for High-Risk and/
or Racial/Ethnicity Minority
Populations, Program Announcement
Number PS09–906, Initial Review
Advisory Committee on Immunization
Practices (ACIP)
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Review of
Competitive Revisions for Training Grant
Applications Under the American Recovery
and Reinvestment Act (ARRA).
Date: June 10, 2009.
Time: 8 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Jeannette F. Korczak, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Room
8115, Bethesda, MD 20892, 301–496–9767,
korczakj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control; 93.701, ARRA Related
Biomedical Research and Research Support
Awards, National Institutes of Health, HHS)
Dated: May 13, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11820 Filed 5–27–09; 8:45 am]
BILLING CODE 4140–01–M
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Times, Dates, and Panels:
8:30 a.m.–5 p.m., June 15, 2009 (Closed).
8:30 a.m.–5 p.m., June 16, 2009 (Closed).
8:30 a.m.–5 p.m., June 17, 2009 (Closed).
8:30 a.m.–12 p.m., June 18, 2009 (Closed).
Place: W Hotel Atlanta–Midtown, 188 14th
Street, NE., Atlanta, Georgia 30361,
Telephone (404) 892–6000.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘Capacity Building Assistance
(CBA) To Improve the Delivery and
Effectiveness of Human Immunodeficiency
Virus (HIV) Prevention Services for HighRisk and/or Racial/Ethnicity Minority
Populations, PS09–906.’’
Contact Person for More Information:
Monica Farmer, M.Ed., Public Health
Analyst, Strategic Science and Program Unit,
Office of the Director, Coordinating Center
for Infectious Diseases, CDC, 1600 Clifton
Road, NE., Mailstop E–60, Atlanta, GA
30333, Telephone: (404) 498–2277.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 19, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–12331 Filed 5–27–09; 8:45 am]
BILLING CODE 4163–18–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Times and Dates:
8 a.m.–6 p.m., June 24, 2009.
8 a.m.–5:45 p.m., June 25, 2009.
8 a.m.–1 p.m., June 26, 2009.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton Road,
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate uses of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines.
Matters To Be Discussed: The agenda will
include discussions on General
Recommendations; Rabies Vaccine;
Poliovirus Vaccine; Measles, Mumps and
Rubella Vaccine; Pneumococcal Vaccines;
Yellow Fever Vaccine; Meningococcal
Vaccine; Japanese Encephalitis; MMRV
Vaccine Safety; Haemophilus influenzae b
(Hib) Vaccine; Vaccine Supply; Hepatitis;
Human Papillomavirus (HPV) Vaccines;
Roles of Pharmacists in Vaccine
Administration; Influenza Vaccines; and
Novel Influenza A (H1N1).
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Antonette Hill, Immunization Services
Division, National Center for Immunization
and Respiratory Diseases, CDC, 1600 Clifton
Road, NE., (E–05), Atlanta, Georgia 30333,
telephone 404/639–8836, fax 404/639–8905.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and Agency for Toxic
Substances and Disease Registry.
Dated: May 19, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–12334 Filed 5–27–09; 8:45 am]
BILLING CODE 4160–18–P
VerDate Nov<24>2008
17:11 May 27, 2009
Jkt 217001
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
E:\FR\FM\28MYN1.SGM
28MYN1
]]>Agencies
[Federal Register Volume 74, Number 101 (Thursday, May 28, 2009)]
[Notices]
[Page 25567]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-12334]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Times and Dates:
8 a.m.-6 p.m., June 24, 2009.
8 a.m.-5:45 p.m., June 25, 2009.
8 a.m.-1 p.m., June 26, 2009.
Place: CDC, Tom Harkin Global Communications Center, 1600
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines.
Matters To Be Discussed: The agenda will include discussions on
General Recommendations; Rabies Vaccine; Poliovirus Vaccine;
Measles, Mumps and Rubella Vaccine; Pneumococcal Vaccines; Yellow
Fever Vaccine; Meningococcal Vaccine; Japanese Encephalitis; MMRV
Vaccine Safety; Haemophilus influenzae b (Hib) Vaccine; Vaccine
Supply; Hepatitis; Human Papillomavirus (HPV) Vaccines; Roles of
Pharmacists in Vaccine Administration; Influenza Vaccines; and Novel
Influenza A (H1N1).
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Antonette Hill,
Immunization Services Division, National Center for Immunization and
Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E-05), Atlanta,
Georgia 30333, telephone 404/639-8836, fax 404/639-8905.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the CDC and Agency for Toxic Substances and
Disease Registry.
Dated: May 19, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-12334 Filed 5-27-09; 8:45 am]
BILLING CODE 4160-18-P
